Cambridge Investment Research Advisors’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Sell
20,488
-893
-4% -$65.1K ﹤0.01% 1884
2026
Q1
$1.4M Buy
21,381
+2,803
+15% +$208K ﹤0.01% 1891
2025
Q4
$1.47M Buy
18,578
+116
+0.6% +$8.88K ﹤0.01% 1791
2025
Q3
$1.35M Buy
18,462
+372
+2% +$27.3K ﹤0.01% 1813
2025
Q2
$1.37M Sell
18,090
-803
-4% -$56.9K ﹤0.01% 1708
2025
Q1
$1.44M Sell
18,893
-895
-5% -$66.7K ﹤0.01% 1584
2024
Q4
$1.31M Sell
19,788
-3,742
-16% -$262K ﹤0.01% 1659
2024
Q3
$1.64M Sell
23,530
-7,372
-24% -$443K 0.01% 1502
2024
Q2
$1.63M Buy
+30,902
New +$1.88M 0.01% 1429

Other funds holding SOLV

Cambridge Investment Research Advisors's SOLV Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Solventum (SOLV) stake by 4.2% in Q2 2026, selling an estimated $65.1K and leaving 20,488 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1884.

Cambridge Investment Research Advisors first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.64M in Q3 2024. 873 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Cambridge Investment Research Advisors held 20,488 shares of Solventum worth $1.58M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 893 Solventum shares in Q2 2026, an estimated $65.1K.
  • Solventum made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1884 holding.
  • Cambridge Investment Research Advisors first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Cambridge Investment Research Advisors's Solventum position peaked at $1.64M in Q3 2024.
  • 873 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.